Icon
+91 94997 68112
Login Register

Invokamet XR - (50/150mg;500mg, 50/150mg;1gm, Tablet, Extended)

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE Janssen Pharma
50/150mg;500mg, 50/150mg;1gm, Tablet, Extended
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
None None
An adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both canagliflozin and metformin is appropriate.
Yes
***** ** *** **** ** ****** ******** ** *** ****. ***** *** ***** **** ** ******* '*** (*** **, ****) *** '*** (*** *, ****) - ** ******* **** ********** ** *********** **** ** *************. *** **** ***** **** ** **** ******* '*** (*** **, ****) *** '*** (*** *, ****) *** *** *********. ******* ********* **** ***** **** ** **** ******* '***, '***, '***, '***, '*** *** *** *********. ******** ****** ** ************* ****** ** *** ****. **, **** ** *** ******** *** ***** ****** *** ****. *****, ********** ******* **** *********, ********* ** ********** ********* ***'* ****** ******* ***** *** ********** ** ******* '*** *** '***. ******** ***** * **** ** *** *** *********. ******* ******* **** ****** ****, ***** *** ***** ** ********** *** *** ***** ** **** **,****.
Invokamet XR Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6
***** *** ********* *******/**** *** ********* *** ********* *******/**** *** *********
*** **** *** ********* ******* ******* *** ********* ******* *** *********
********* ******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ** *** **,**** ******* ********* ******** ***** *** ****
*** **** ** \ ** *** **, **** ******* **** ***** *** ****
********* ** \ ** **** **, **** ******* **** ***** *** ****
  1. *** **, **** : ***** ******** ********** ****** ***** *** **** ** ****** **** ********* ** *** ******* ******* (*** **,****) *** ******* (*** *,****)
  2. *** **, **** : ********** ****** ***** * **** ******* ***** ** ******* ******* (*** **,****) *** ******* (*** *,****)
  3. *** **, **** : *** **** ******** ********** ****** ***** *** **** ** ****** **** ********* ** *** ******* ******* (*** **,****) *** ******* (*** *,****)
  4. *** **, **** : ********** ****** ***** * **** ******* *** **** ** ******* ******* (*** **,****) *** ******* (*** *,****)
  5. *** *, **** : ********* ******** ********** ***** **'* **** ** ****** ** ******* '***, '***, '***, '*** *** '***.
  6. *** **, **** : ********** ***** * **** ******* ********* ** ******* '***, '***, '***, '*** *** '***.
  7. *** **, **** : ********** ******* **** *********, ********* ** ********** ********* ***'* ****** ******* ***** *** ********** ** ******* '*** *** '***
  8. *** **, **** : ******** ******** ********** ****** ***** *** **** ** ******
  9. *** **, **** : ********** ****** ***** * **** ******* ******** ** ******* '*** *** '***.
  10. *** **, **** : ********** ********* ****** **** ********* *** ******* **** *****, ***** *** ***** ** ********** *** *** *****.
  11. *** **, **** : ********** ******* **** *** **** ***** *** ***** ** ********** *** *** *****.
  12. *** **, **** : ********** ******* **** ******** ** ******* *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.